Cycloaspeptide A
- $141 - $540
- Product name: Cycloaspeptide A
- CAS: 109171-13-3
- MF: C36H43N5O6
- MW: 641.76
- EINECS:
- MDL Number:MFCD08274568
- Synonyms:Cyclo(L-alanyl-N-methyl-L-phenylalanyl-L-leucyl-N-methyl-L-tyrosyl-2-aminobenzoyl)
4 prices
Selected condition:
Brand
- Adipogen Life Sciences
- AK Scientific
- Cayman Chemical
- TRC
Package
- 1mg
- 5mg
- ManufacturerAdipogen Life Sciences
- Product numberAG-CN2-0148-M005
- Product descriptionCycloaspeptideA ≥95%(HPLC)
- Packaging5mg
- Price$540
- Updated2021-12-16
- Buy
- ManufacturerAK Scientific
- Product number6614CS
- Product descriptionCycloaspeptideA
- Packaging1mg
- Price$260
- Updated2021-12-16
- Buy
- ManufacturerCayman Chemical
- Product number28744
- Product descriptionCycloaspeptide A
- Packaging1mg
- Price$141
- Updated2024-03-01
- Buy
- ManufacturerTRC
- Product numberC987858
- Product descriptionCycloaspeptideA
- Packaging1mg
- Price$145
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Adipogen Life Sciences | AG-CN2-0148-M005 | CycloaspeptideA ≥95%(HPLC) | 5mg | $540 | 2021-12-16 | Buy |
AK Scientific | 6614CS | CycloaspeptideA | 1mg | $260 | 2021-12-16 | Buy |
Cayman Chemical | 28744 | Cycloaspeptide A | 1mg | $141 | 2024-03-01 | Buy |
TRC | C987858 | CycloaspeptideA | 1mg | $145 | 2021-12-16 | Buy |
Properties
Boiling point :971.1±65.0 °C(Predicted)
Density :1.161±0.06 g/cm3(Predicted)
storage temp. :Store at -20°C
solubility :Dichloromethane: soluble,DMSO: soluble,Ethanol: soluble,Methanol: soluble
form :White to off-white crystalline solid.
pka :9.89±0.15(Predicted)
color :White crystalline
Density :1.161±0.06 g/cm3(Predicted)
storage temp. :Store at -20°C
solubility :Dichloromethane: soluble,DMSO: soluble,Ethanol: soluble,Methanol: soluble
form :White to off-white crystalline solid.
pka :9.89±0.15(Predicted)
color :White crystalline
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|